Effectiveness of Dry Needling of the Gastrocnemius Muscle VS Electrolysis in Subjects With Achilles Tendinopathy

Sponsor
Universidad Católica de Ávila (Other)
Overall Status
Recruiting
CT.gov ID
NCT06080334
Collaborator
(none)
80
1
2
10
8

Study Details

Study Description

Brief Summary

Achilles tendinopathy is the injury that primarily occurs in athletes and people who engage in repetitive activities that involve the calf muscles, such as running, jumping, and sudden acceleration and deceleration movements. To observe the effectiveness of dry needling in the PGM of the gastrocnemius muscle, in the short and medium term, on the intensity of pain in gastrocnemius muscle, in the short and medium term, on pain intensity in patients with patients with Achilles tendinopathy, compared to the application of ultrasound-guided percutaneous electrolysis on the tendon.

Condition or Disease Intervention/Treatment Phase
  • Device: Dry needling
  • Device: Electrolysis
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Health Services Research
Official Title:
Effectiveness of Dry Needling of the Gastrocnemius Muscle vs. Electrolysis in Subjects With Achilles Tendinopathy: a Randomised Single-blind Clinical Trial
Anticipated Study Start Date :
Nov 1, 2023
Anticipated Primary Completion Date :
Apr 30, 2024
Anticipated Study Completion Date :
Sep 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Dry needling+eccentric exercises

Application of dry needling on the hyperalgesic trigger points of the gastrocnemius muscle and subsequent inclusion of eccentric exercises.

Device: Dry needling
Dry needling using the Hong technique on the most hyperalgesic trigger point in the gastrocnemius muscle.

Experimental: Electrolysis+eccentric exercises

Application of electrolysis to the Achilles tendon and subsequent inclusion of eccentric exercises.

Device: Electrolysis
Electrolysis on the Achilles tendon using ultrasound-guided technique.

Outcome Measures

Primary Outcome Measures

  1. Pain intensity. [5 weeks]

    Measurement of pain intensity using the VAS scale (0 minimum pain, 10 maximum bearable pain).

Secondary Outcome Measures

  1. Pressure pain threshold [5 weeks]

    Pressure pain threshold measured by algometer over the most hyperalgesic point on the Achilles tendon measured in Newtons.

  2. Range of movement [5 weeks]

    Measurement of ankle dorsiflexion range of motion measured by digital goniometer.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Signing of informed consent both to participate in the study and to undergo invasive in the study, as well as to undergo invasive physiotherapy techniques. physiotherapy techniques.

  • Presence of symptoms (swelling or pain) for at least 3 months.

  • Positive Achilles tendon palpation test.

  • Males and females over 18 years of age.

  • Presence of MMP in the gastrocnemius muscle, meeting at least three of the following criteria diagnostic criteria described by Travell and Simons:

  • Presence of palpable tight band.

  • Local pain on pressure at the nodule of the tense band.

  • Recognition by the patient as his usual pain after mechanical after mechanical stimulation of the sensitive nodule.

  • Limitation of range of motion.

Exclusion Criteria:
  • Any related acute or chronic musculoskeletal disease that may related chronic musculoskeletal disease, which may affect the results of the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Jorge Velázquez Saornil Ávila Spain 05005

Sponsors and Collaborators

  • Universidad Católica de Ávila

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
JORGE VELAZQUEZ SAORNIL, Principal investigator, Universidad Católica de Ávila
ClinicalTrials.gov Identifier:
NCT06080334
Other Study ID Numbers:
  • 06/10/2023
First Posted:
Oct 12, 2023
Last Update Posted:
Oct 12, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by JORGE VELAZQUEZ SAORNIL, Principal investigator, Universidad Católica de Ávila
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 12, 2023